IGF1 and adenoma: As confirmed by other studies, these patients, presenting with higher IGF-1 levels at diagnosis, generally exhibit a milder phenotype– i.e., smaller and less invasive adenomas– compared to those with a conventional GH response after OGTT [22–24].